Ahmed Kotb/daiichisankyo.us
Jul 18, 2026, 20:15
Ahmed Kotb: Exploring Qualitative Platelet Defects
Ahmed Kotb, Head of Global Oncology Medical Affairs at Daiichi Sankyo, shared a post on X:
“Qualitative Platelet Defects
Inherited
- Glanzmann: low GPIIb/IIIa – No aggregation except ristocetin
- Bernard–Soulier: low GPIb – Abnormal ristocetin
- Storage pool disease: Absent 2ry wave
Acquired
- Drugs:Aspirin, Clopidogrel, GP IIb/IIIa inhibitor
- Diseases: Uremia, liver disease”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 21:05Federica Fedele: From One-Size-Fits-All to Personalized Care
-
Jul 18, 2026, 21:04Sandra Rodríguez Coma: A Great Experience With the Werfen Team at ISTH 2026
-
Jul 18, 2026, 20:58Heghine Khachatryan: Cancer-Associated ATE – An Underrecognized Challenge in Modern Oncology
-
Jul 18, 2026, 20:57Barbara Adams Krolak: The Science Was Even Hotter Than Paris
-
Jul 18, 2026, 20:08Bianca Heidersdorf: Shaping the Future of Bleeding Disorders Support at ISTH 2026
-
Jul 18, 2026, 18:00Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
-
Jul 18, 2026, 17:34Living With ITP – A New Resource for Navigating Your Diagnosis – ITP Support Association
-
Jul 18, 2026, 17:34Mona Alfaraj: It Was a Hot Week Attending ISTH 2026 Congress in Paris
-
Jul 18, 2026, 17:26Shernan Holtan: Latest Publication on PTCy